Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : World Heart Corp - WHRT and TSE/WHT -- Ignore unavailable to you. Want to Upgrade?

To: Dan Hamilton who wrote (424)	4/26/2000 4:26:00 PM
From: William Marsh	Read Replies (1) \| Respond to of 500

Yes, exactly. These are the tests which will occur over the 2nd and 3rd qrt, which are on schedule. 6 months for testing, 45 days for approval - this still leaves them 45 days for initial human implant this year. The production capacity is sufficient to support the tests. The battery component manufacturing lags the other production a bit but this was anticipated and will not delay testing. Recent reorgs at Health Canada does not effect medical devices section. Health Canada is being kept fully informed. Some old news repeated: They will apply for approval in Canada, then Europe and South America, then US. A bit of new news (new to me anyway): they think that approaching US regulators with clinical data from Canada and US will assist approval in the US. (This makes sense, of course, but wasn't a given, considering we are dealing with the Yanks.) Bill